•  
  •  

Medicines to Prevent Respiratory Syncytial Virus (RSV) Infection

Preventive medicines are usually used only for babies and children who have a higher risk of having complications if they become infected with respiratory syncytial virus (RSV). These medicines are not used to treat someone who already has RSV infection.

Palivizumab (Synagis) is a medicine containing laboratory-produced antibodies designed to help prevent RSV infections. RSV infections that develop despite being given this medicine are usually less severe. Palivizumab is given by injection into the muscle (intramuscular, or IM) once a month during the winter months.

No standard preventive immunization exists because there is more than one type of RSV and many subtypes (strains). Researchers are trying to develop a vaccine that is effective for the general population at a reasonable cost.

By Healthwise Staff
Primary Medical Reviewer John Pope, MD - Pediatrics
Specialist Medical Reviewer Thomas Emmett Francoeur, MDCM, CSPQ, FRCPC - Pediatrics
Last Revised July 9, 2010

Last Revised: July 9, 2010

Author: Healthwise Staff

Medical Review: John Pope, MD - Pediatrics & Thomas Emmett Francoeur, MDCM, CSPQ, FRCPC - Pediatrics

This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

To learn more visit Healthwise.org

© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.